In 2004, strange things were happening when people living in the Southern United States received Erbitux, an anticancer drug. After Erbitux was approved, the first three patients that oncologist Bert O'Neil treated at the University of North Carolina, Chapel Hill, had severe anaphylactic reactions. "One fell out of their chair," passing out as blood pressure plummeted. "It alarmed us."
Advertisement
Survey Series
For Advertisers
A Southern mystery
|
|||||||||
|
|||||||||
|
